-
-
-
-
-
-
-
Tyra Biosciences (TYRA) Reiterated at Overweight by Cantor Fitzgerald
-
-
-
-
-
-
-
William Blair Starts Tyra Biosciences (TYRA) at Outperform
-
-
-
-
-
-
-
Tyra Biosciences (TYRA) PT Raised to $36 at Oppenheimer
-
-
-
-
-
-
-
Tyra Biosciences (TYRA) Appoints Adele Gulfo to its Board
-
-
-
-
-
-
-
Tyra Biosciences (TYRA) Receives IND Clearance from FDA to Proceed with Phase 2 Study of TYRA-300 in Pediatric Achondroplasia
-
-
-
-
-
-
-
Piper Sandler Reiterates Overweight Rating on Tyra Biosciences (TYRA)
-
-
-
-
-
-
-
Tyra Biosciences (TYRA) Announces Preclinical Proof-of-Concept Results with TYRA-300
430,614 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

